Canada Research Roundup: Boralex, Dream Unlimited, Stantec

DREAM Unlimited

24/02/2022 07:14

Feb 24 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Boralex, Dream Unlimited and Stantec, on Thursday. 

    HIGHLIGHTS    
     * Boralex Inc  BLX.TO : National Bank of Canada raises target price to C$42 from C$41
     * Dream Unlimited Corp  DRM.TO : CIBC raises target price to C$52 from C$37
     * Stantec Inc  STN.TO : National Bank of Canada raises to outperform from sector perform
        
Following is a summary of research actions on Canadian companies reported by Reuters on
Thursday. Stock entries are in alphabetical order.       
    
     * Boralex Inc  BLX.TO : National Bank of Canada raises target price to C$42 from C$41
     * Dream Unlimited Corp  DRM.TO : CIBC raises target price to C$52 from C$37
     * Gildan Activewear Inc  GIL.TO : Desjardins Securities raises PT to C$63 from C$59
     * Gildan Activewear Inc  GIL.TO : National Bank of Canada raises PT to C$65 from C$59
     * KP Tissue Inc  KPT.TO : National Bank of Canada raises target price to C$11 from C$10.50
     * Stantec Inc  STN.TO : National Bank of Canada raises to outperform from sector perform
     * Thinkific Labs Inc  THNC.TO : CIBC cuts target price to C$10 from C$15
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))